Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1997 2
1998 1
1999 1
2007 1
2008 2
2009 4
2010 4
2011 8
2012 10
2013 4
2014 2
2015 2
2016 2
2017 1
2018 2
2019 1
2020 5
2021 3
2022 2
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
Immunoglobulins in systemic sclerosis management. A large multicenter experience.
Tandaipan J, Guillén-Del-Castillo A, Simeón-Aznar CP, Carreira PE, De la Puente C, Narváez J, Lluch J, Rubio-Rivas M, Alegre-Sancho JJ, Bonilla G, Moriano C, Casafont-Sole I, García-Vicuña R, Ortiz-Santamaría V, Riera E, Atienza-Mateo B, Blanco R, Galisteo C, Gonzalez-Martin JJ, Pego-Reigosa JM, Pros A, Heredia S, Castellví I. Tandaipan J, et al. Among authors: pros a. Autoimmun Rev. 2023 Nov;22(11):103441. doi: 10.1016/j.autrev.2023.103441. Epub 2023 Sep 12. Autoimmun Rev. 2023. PMID: 37708984 Review.
Leflunomide: A safe and effective alternative in systemic lupus erythematosus.
Carrión-Barberà I, Polino L, Mejía-Torres M, Pérez-García C, Ciria M, Pros A, Rodríguez-García E, Monfort J, Salman-Monte TC. Carrión-Barberà I, et al. Among authors: pros a. Autoimmun Rev. 2022 Feb;21(2):102960. doi: 10.1016/j.autrev.2021.102960. Epub 2021 Sep 22. Autoimmun Rev. 2022. PMID: 34560304 No abstract available.
Calcium as a treatment of osteoporosis.
Blanch J, Pros A. Blanch J, et al. Among authors: pros a. Drugs Today (Barc). 1999 Aug;35(8):631-9. doi: 10.1358/dot.1999.35.8.552219. Drugs Today (Barc). 1999. PMID: 12973426
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways.
López-Isac E, Acosta-Herrera M, Kerick M, Assassi S, Satpathy AT, Granja J, Mumbach MR, Beretta L, Simeón CP, Carreira P, Ortego-Centeno N, Castellvi I, Bossini-Castillo L, Carmona FD, Orozco G, Hunzelmann N, Distler JHW, Franke A, Lunardi C, Moroncini G, Gabrielli A, de Vries-Bouwstra J, Wijmenga C, Koeleman BPC, Nordin A, Padyukov L, Hoffmann-Vold AM, Lie B; European Scleroderma Group†; Proudman S, Stevens W, Nikpour M; Australian Scleroderma Interest Group (ASIG); Vyse T, Herrick AL, Worthington J, Denton CP, Allanore Y, Brown MA, Radstake TRDJ, Fonseca C, Chang HY, Mayes MD, Martin J. López-Isac E, et al. Nat Commun. 2019 Oct 31;10(1):4955. doi: 10.1038/s41467-019-12760-y. Nat Commun. 2019. PMID: 31672989 Free PMC article.
A multicenter study confirms CD226 gene association with systemic sclerosis-related pulmonary fibrosis.
Bossini-Castillo L, Simeon CP, Beretta L, Broen JC, Vonk MC, Ríos-Fernández R, Espinosa G, Carreira P, Camps MT, Castillo MJ, González-Gay MA, Beltrán E, Carmen Freire Md, Narváez J, Tolosa C, Witte T, Kreuter A, Schuerwegh AJ, Hoffmann-Vold AM, Hesselstrand R, Lunardi C, van Laar JM, Chee MM, Herrick A, Koeleman BP, Denton CP, Fonseca C, Radstake TR, Martin J; Spanish Scleroderma Group. Bossini-Castillo L, et al. Arthritis Res Ther. 2012 Apr 24;14(2):R85. doi: 10.1186/ar3809. Arthritis Res Ther. 2012. PMID: 22531499 Free PMC article.
51 results